These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29890069)

  • 21. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
    Monogue ML; Sakoulas G; Nizet V; Nicolau DP
    Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Cheng J; Yan J; Reyna Z; Slarve M; Lu P; Spellberg B; Luna B
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
    Liu B; Liu Y; Di X; Zhang X; Wang R; Bai Y; Wang J
    Rev Soc Bras Med Trop; 2014 Jul; 47(4):451-6. PubMed ID: 25229285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.
    Garcia Casallas JC; Robayo-Amortegui H; Corredor-Rozo Z; Carrasco-Márquez AM; Escobar-Perez J
    J Med Case Rep; 2019 May; 13(1):141. PubMed ID: 31064407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method.
    Hatipoglu H; Kilbas I; Kilic U; Yilmaz K; Koroglu M; Altindis M
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549991
    [No Abstract]   [Full Text] [Related]  

  • 27. Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.
    Kempf M; Djouhri-Bouktab L; Brunel JM; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):180-1. PubMed ID: 22100281
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.
    Parra-Millán R; Vila-Farrés X; Ayerbe-Algaba R; Varese M; Sánchez-Encinales V; Bayó N; Pachón-Ibáñez ME; Teixidó M; Vila J; Pachón J; Giralt E; Smani Y
    J Antimicrob Chemother; 2018 Dec; 73(12):3405-3412. PubMed ID: 30188994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.
    Presta L; Bosi E; Mansouri L; Dijkshoorn L; Fani R; Fondi M
    Sci Rep; 2017 Jun; 7(1):3706. PubMed ID: 28623298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates.
    Srinivas P; Hunt LN; Pouch SM; Thomas K; Goff DA; Pancholi P; Balada-Llasat JM; Bauer KA
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):194-198. PubMed ID: 29482871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Molecule Potentiation of Gram-Positive Selective Antibiotics against
    Martin SE; Melander RJ; Brackett CM; Scott AJ; Chandler CE; Nguyen CM; Minrovic BM; Harrill SE; Ernst RK; Manoil C; Melander C
    ACS Infect Dis; 2019 Jul; 5(7):1223-1230. PubMed ID: 31002491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
    Nepka M; Perivolioti E; Kraniotaki E; Politi L; Tsakris A; Pournaras S
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6903-6906. PubMed ID: 27550356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.
    Chen Z; Chen Y; Fang Y; Wang X; Chen Y; Qi Q; Huang F; Xiao X
    Sci Rep; 2015 Nov; 5():17091. PubMed ID: 26597507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
    Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.